Corient Ia LLC Eli Lilly & CO Transaction History
Corient Ia LLC
- $141 Billion
- Q1 2025
A detailed history of Corient Ia LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Corient Ia LLC holds 690 shares of LLY stock, worth $521,343. This represents 0.4% of its overall portfolio holdings.
Number of Shares
690Holding current value
$521,343% of portfolio
0.4%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
4,378Shares Held
821MCall Options Held
10.1MPut Options Held
11.6M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$76.5 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$72.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$59.9 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.8 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.3MShares$25.9 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $718B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...